<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04564131</url>
  </required_header>
  <id_info>
    <org_study_id>SY200217B06</org_study_id>
    <nct_id>NCT04564131</nct_id>
  </id_info>
  <brief_title>Reflexology in Diabetic Neuropathic Pain Management</brief_title>
  <official_title>The Effect of Reflexology Massage Applied to Diabetic Neuropathic Pain on Patients Quality of Life</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul Saglik Bilimleri University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul Saglik Bilimleri University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Reflexology massage, applied by applying pressure to any point on the feet, is one of the&#xD;
      most popular complementary treatments in the world. Given the negative impact of neuropathic&#xD;
      pain on quality of life and the limited effectiveness of traditional medicines, it is&#xD;
      important to investigate the effects of various complementary therapies available, including&#xD;
      reflexology massage. Therefore, the study was planned as a prospective randomized controlled&#xD;
      experimental study with a pre-test and post-test design aiming to investigate the effect of&#xD;
      reflexology massage for neuropathic pain on pain intensity and quality of life in diabetic&#xD;
      individuals.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pressure will be applied to the relevant reflex areas of the foot based on the individual's&#xD;
      pain area. In order to standardize the application, the procedure will start with the left&#xD;
      foot and end with the right foot. Both feet will be massaged using petroleum jelly for 5&#xD;
      minutes of relaxation movements, 5 minutes of general foot massage and 5 minutes of standing&#xD;
      and reflex area corresponding to the painful body area. 5 more minutes will be applied to the&#xD;
      left foot in order to increase the endorphin secretion and reduce the pain by activating the&#xD;
      parasympathetic system. Reflexology massage will be applied for a total of 35 minutes in one&#xD;
      session. Each reflexology area will be stimulated 15 times, as less than 10 stimulation to a&#xD;
      particular reflexology area does not produce any therapeutic effect and more than 20&#xD;
      stimulations will be excessive. A total of 3 follow-ups will be done throughout the study. In&#xD;
      the follow-up sessions; Visual Analogue Scale (VAS), Douleur Neuropathique 4 (DN4), The Leeds&#xD;
      Assessment of Neuropathic Symptoms and Signs (LANSS) , Neuropathic Pain Impact on&#xD;
      Quality-of-Life questionnaire (NePIQoL) scales will be applied, foot assessment and SWMI test&#xD;
      will be applied. The 1st follow-up will be done before any intervention in the 1st session,&#xD;
      the 2nd follow-up will be done after the reflexology application in the 5th session, and the&#xD;
      3rd follow-up will be done after the reflexology application at the 10th session . There will&#xD;
      be a break of at least one day between two sessions to relax the body and eliminate toxins.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2021</start_date>
  <completion_date type="Anticipated">April 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain intensity</measure>
    <time_frame>5 Months</time_frame>
    <description>According to the Douleur Neuropathique 4 Questions (DN4) questionnaire, neuropathic pain score changes to less than 4 points.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pain intensity</measure>
    <time_frame>5 Months</time_frame>
    <description>Change of neuropathic pain score to less than 12 points according to The Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>life quality</measure>
    <time_frame>5 Months</time_frame>
    <description>Change of quality of life score higher than 42 points according to the Neuropathic Pain Impact on Quality-of Life Questionnaire (NePIQoL) scale</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Reflexology</condition>
  <condition>Neuropathic Pain</condition>
  <arm_group>
    <arm_group_label>reflexology practice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blood glucose measurement with a glucometer to be provided by the researcher, blood pressure measurement with a digital blood pressure device, and foot temperature measurement with an infrared thermometer will be made. Turkey podiatry foot care guide will be trained under the guidance of the Society of Endocrinology and Metabolism.&#xD;
Experimental group participants will be given 10 sessions of reflexology massage twice a week for 5 weeks. A total of three follow-ups will be performed in the 1st session, the 5th session and the 10th session. In the follow-up sessions; VAS, DN4, LANSS, NePIQol scales will be applied, foot assessment and SWMI test will be applied.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blood glucose measurement with a glucometer to be provided by the researcher, blood pressure measurement with a digital blood pressure device, and foot temperature measurement with an infrared thermometer will be made. Turkey podiatry foot care guide will be trained under the guidance of the Society of Endocrinology and Metabolism. 1. 3. 5. A total of three follow-ups will be done once in the week. In the follow-up sessions; VAS, DN4, LANSS, NePIQol scales will be applied, foot assessment and SWMI test will be applied.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Reflexology</intervention_name>
    <description>Hands are washed.&#xD;
The individual is provided to be in a comfortable position to lie down or to be in a semi-sitting position.&#xD;
The toes of the patient are crossed and the patient's feet are placed at our chest level when we sit.&#xD;
Depending on the size of the foot, a slightly moisturizing amount of non-allergenic petroleum jelly is taken, and it is spread to provide slipperiness.&#xD;
Exercises to warm and relax the feet for five minutes.&#xD;
General massage is applied to the whole foot for five minutes.&#xD;
Reflexology massage is applied to the application areas for neuropathic pain.&#xD;
The individual is helped to take a comfortable position.&#xD;
Hands are washed.</description>
    <arm_group_label>reflexology practice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>No intervention was performed to reduce pain in the control group</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Those over the age of 18,&#xD;
&#xD;
          -  Literate,&#xD;
&#xD;
          -  A diagnosis of neuropathic pain associated with Type 2 diabetes,&#xD;
&#xD;
          -  Defined pain of at least 4 severity according to the Visual Analogue Scale (VAS),&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  A diagnosis of disease causing neuropathy (uremia, malnutrition, liver failure,&#xD;
             alcoholism, kidney failure, dialysis treatment, oncology patients, vitamin&#xD;
             deficiency),&#xD;
&#xD;
          -  have a pacemaker,&#xD;
&#xD;
          -  Diabetic foot diagnosis,&#xD;
&#xD;
          -  who are pregnant,&#xD;
&#xD;
          -  Having vision, hearing, cognitive ability disorders and psychosis, Reflexology massage&#xD;
             in the last month,&#xD;
&#xD;
          -  Receiving medical treatment with an effect that conceals neuropathic pain symptoms,&#xD;
&#xD;
          -  Disc herniation,&#xD;
&#xD;
          -  Any infectious skin disease (shingles, fungus, etc.),&#xD;
&#xD;
          -  Individuals with open lesions / wounds, scar tissue, fractures, dislocations,&#xD;
             amputation, edema, hematoma, thrombophlebitis, inflamed and degenerative joint&#xD;
             diseases in the lower extremities will not be included in the sample.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nesibe Simsekoglu, RN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saglik Bilimleri University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nesibe Simsekoglu, RN</last_name>
    <phone>+90 553 931 97 91</phone>
    <email>nesibesimsek._@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Merdiye Sendir, Prof. Dr.</last_name>
    <phone>(216) 418 96 16</phone>
    <phone_ext>2301</phone_ext>
    <email>merdiye.sendir@sbu.edu.tr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Saglik Bilimleri University</name>
      <address>
        <city>Istanbul</city>
        <zip>34000</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Silva NCM, Chaves ÉCL, Carvalho EC, Carvalho LC, Iunes DH. Effect of Foot Reflexology on Capillary Blood Glucose, Tissue Temperature, and Plantar Pressure of Individuals With Diabetes Mellitus (Type 2): A Pilot Study. J Chiropr Med. 2018 Sep;17(3):182-189. doi: 10.1016/j.jcm.2018.03.003. Epub 2018 Aug 26.</citation>
    <PMID>30228809</PMID>
  </reference>
  <reference>
    <citation>Dalal K, Maran VB, Pandey RM, Tripathi M. Determination of efficacy of reflexology in managing patients with diabetic neuropathy: a randomized controlled clinical trial. Evid Based Complement Alternat Med. 2014;2014:843036. doi: 10.1155/2014/843036. Epub 2014 Jan 9.</citation>
    <PMID>24527055</PMID>
  </reference>
  <reference>
    <citation>Wändell PE, Carlsson AC, Gåfvels C, Andersson K, Törnkvist L. Measuring possible effect on health-related quality of life by tactile massage or relaxation in patients with type 2 diabetes. Complement Ther Med. 2012 Feb-Apr;20(1-2):8-15. doi: 10.1016/j.ctim.2011.09.007. Epub 2011 Oct 22.</citation>
    <PMID>22305243</PMID>
  </reference>
  <reference>
    <citation>Gok Metin Z, Arikan Donmez A, Izgu N, Ozdemir L, Arslan IE. Aromatherapy Massage for Neuropathic Pain and Quality of Life in Diabetic Patients. J Nurs Scholarsh. 2017 Jul;49(4):379-388. doi: 10.1111/jnu.12300. Epub 2017 Jun 12.</citation>
    <PMID>28605119</PMID>
  </reference>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>August 28, 2020</study_first_submitted>
  <study_first_submitted_qc>September 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 25, 2020</study_first_posted>
  <last_update_submitted>September 24, 2020</last_update_submitted>
  <last_update_submitted_qc>September 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul Saglik Bilimleri University</investigator_affiliation>
    <investigator_full_name>Nesibe Simsekoglu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Type 2 Diabetes</keyword>
  <keyword>Quality of Life</keyword>
  <keyword>Nursing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuralgia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

